Free Trial

National Research (NRC) to Release Quarterly Earnings on Tuesday

National Research (NASDAQ:NRC - Get Free Report) is set to post its quarterly earnings results after the market closes on Tuesday, May 7th. Individual interested in registering for the company's earnings conference call can do so using this link.

National Research (NASDAQ:NRC - Get Free Report) last announced its quarterly earnings data on Tuesday, February 13th. The company reported $0.36 earnings per share (EPS) for the quarter. The company had revenue of $38.00 million for the quarter. National Research had a return on equity of 47.79% and a net margin of 20.84%.

National Research Stock Down 0.1 %

NASDAQ NRC traded down $0.05 during midday trading on Tuesday, hitting $34.25. 48,956 shares of the company traded hands, compared to its average volume of 70,695. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.67 and a quick ratio of 0.67. The company has a market cap of $816.86 million, a PE ratio of 27.40 and a beta of 0.42. The company's 50-day simple moving average is $37.96 and its 200-day simple moving average is $39.59. National Research has a 52 week low of $32.08 and a 52 week high of $47.25.


National Research Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Friday, March 29th were paid a $0.12 dividend. The ex-dividend date was Wednesday, March 27th. This represents a $0.48 dividend on an annualized basis and a yield of 1.40%. National Research's dividend payout ratio (DPR) is 38.40%.

Analyst Upgrades and Downgrades

Separately, TheStreet cut National Research from a "b-" rating to a "c+" rating in a report on Thursday, January 11th.

Read Our Latest Analysis on NRC

About National Research

(Get Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Featured Articles

Earnings History for National Research (NASDAQ:NRC)

Should you invest $1,000 in National Research right now?

Before you consider National Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.

While National Research currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: